Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2133|178|1|e69-e69

ISSN: 0007-0963

Source: BRITISH JOURNAL OF DERMATOLOGY, Vol.178, Iss.1, 2018-01, pp. : e69-e69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content